194 related articles for article (PubMed ID: 3081038)
1. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
2. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
Inui K; Wenger DA
Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts.
Fujibayashi S; Wenger DA
J Biol Chem; 1986 Nov; 261(32):15339-43. PubMed ID: 3771578
[TBL] [Abstract][Full Text] [Related]
4. The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10.
Inui K; Kao FT; Fujibayashi S; Jones C; Morse HG; Law ML; Wenger DA
Hum Genet; 1985; 69(3):197-200. PubMed ID: 3980013
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
Schmid B; Paton BC; Sandhoff K; Harzer K
Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
[TBL] [Abstract][Full Text] [Related]
6. Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.
Inui K; Emmett M; Wenger DA
Proc Natl Acad Sci U S A; 1983 May; 80(10):3074-7. PubMed ID: 6134282
[TBL] [Abstract][Full Text] [Related]
7. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
[TBL] [Abstract][Full Text] [Related]
8. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
Rafi MA; Amini S; Zhang XL; Wenger DA
Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
[TBL] [Abstract][Full Text] [Related]
9. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency.
Wenger DA; DeGala G; Williams C; Taylor HA; Stevenson RE; Pruitt JR; Miller J; Garen PD; Balentine JD
Am J Med Genet; 1989 Jun; 33(2):255-65. PubMed ID: 2764035
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of surfactant-associated glycoprotein A by rat type II epithelial cells. Primary translation products and post-translational modification.
Whitsett JA; Weaver T; Hull W; Ross G; Dion C
Biochim Biophys Acta; 1985 Apr; 828(2):162-71. PubMed ID: 2858220
[TBL] [Abstract][Full Text] [Related]
13. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy.
Rafi MA; Zhang XL; DeGala G; Wenger DA
Biochem Biophys Res Commun; 1990 Jan; 166(2):1017-23. PubMed ID: 2302219
[TBL] [Abstract][Full Text] [Related]
14. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
[TBL] [Abstract][Full Text] [Related]
15. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
16. Processing of human acid sphingomyelinase in normal and I-cell fibroblasts.
Hurwitz R; Ferlinz K; Vielhaber G; Moczall H; Sandhoff K
J Biol Chem; 1994 Feb; 269(7):5440-5. PubMed ID: 8106525
[TBL] [Abstract][Full Text] [Related]
17. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of asparagine-linked sugar chains of sphingolipid activator protein 1 purified from normal human liver and GM1 gangliosidosis (type 1) liver.
Yamashita K; Inui K; Totani K; Kochibe N; Furukawa M; Okada S
Biochemistry; 1990 Mar; 29(12):3030-9. PubMed ID: 2110822
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]